Approval · Notice of Compliance 1060 · 2003
APO-HYDROXYUREA: Notice of Compliance 1060
Issued September 18, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1060
- Date
- September 18, 2003
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antineoplastic
- Canadian reference product
- HYDREA (Squibb Canada Inc., Division Of Bristol-Myers Squibb Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-HYDROXYUREA | 02247937 | Marketed |
Medicinal ingredients
- HYDROXYUREA 500 MG per CAP